iRhythm Technologies Inc (STU:I25)
€ 83.5 4 (5.03%) Market Cap: 2.60 Bil Enterprise Value: 2.80 Bil PE Ratio: 0 PB Ratio: 38.81 GF Score: 67/100

iRhythm Technologies Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 09:30PM GMT
Release Date Price: €81 (+1.25%)
K. Gong
JPMorgan Chase & Co, Research Division - Associate

Okay. Thanks, everyone, for being here. Hope you guys had a good lunch. My name is Allen Gong. I'm on the medical supplies and devices team here at JPMorgan. I'm really pleased to be introducing members of the iRhythm management team. We're going to be starting off with prepared remarks from CEO, Quentin Blackford, and then opening up for Q&A afterwards.

Quentin S. Blackford
iRhythm Technologies, Inc. - President, CEO & Director

Terrific. Well, thanks for having me, and good afternoon, everybody. It's great to be here. Just a quick reminder as we get started, I am going to be making some forward-looking statements over the course of this presentation. I'd refer you to our annual filings, 10-K, 10-Q for any further information that you might be looking for there. iRhythm is a company that's focused on disrupting the way cardiac arrhythmias are being detected in the marketplace today.

If you think about the traditional Holter monitor, it's been in the marketplace for decades, hasn

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot